Scott, R., Morgan, J., Zimmer, Z., Lam, R. L. H., O'Neill, E. A., Kaufman, K. D., . . . Raji, A. (2018). A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT‐R study. Diabetes Obes Metab.
Citação norma ChicagoScott, Russell, Jerry Morgan, Zachary Zimmer, Raymond L. H. Lam, Edward A. O'Neill, Keith D. Kaufman, Samuel S. Engel, and Annaswamy Raji. "A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared With Dapagliflozin in Patients With Type 2 Diabetes Mellitus and Mild Renal Insufficiency: The CompoSIT‐R Study." Diabetes Obes Metab 2018.
Citação norma MLAScott, Russell, et al. "A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared With Dapagliflozin in Patients With Type 2 Diabetes Mellitus and Mild Renal Insufficiency: The CompoSIT‐R Study." Diabetes Obes Metab 2018.